Company | SRX | Sirtex Medical News, Analysis, Announcements and Results | The Sydney Morning Herald

Sirtex Medical

Advertisement
Former Sirtex boss released after insider trading conviction

Former Sirtex boss released after insider trading conviction

Former Sirtex CEO Gilman Edwin Wong was sentenced to 18 months imprisonment on Thursday but released on a good behaviour bond after being convicted of insider trading.

  • by Colin Kruger

Latest

Former Sirtex boss pleads guilty to insider trading

Former Sirtex boss pleads guilty to insider trading

The former head of medical group Sirtex, Gilman Wong, pleaded guilty to one charge of insider trading, said the Australian Securities and Investments Commission.

  • by Colin Kruger
Donald Trump unlikely to turn away $1.9b Chinese bid, says Sirtex boss

Donald Trump unlikely to turn away $1.9b Chinese bid, says Sirtex boss

Donald Trump’s diplomatic tensions with China unlikely to stop regulatory approval of the $1.9 billion Chinese takeover of Sirtex Medical.

  • by Nassim Khadem
Sirtex Medical goodbyes Varian, backs $1.9b Chinese offer from CDH

Sirtex Medical goodbyes Varian, backs $1.9b Chinese offer from CDH

Sirtex Medical’s board has announced it is backing China's CDH Investments' $1.9 billion bid for the medical device maker.

  • by Nassim Khadem
Varian asks court to allow Sirtex shareholders consider takeover bid

Varian asks court to allow Sirtex shareholders consider takeover bid

US cancer treatment developer Varian is seeking a Federal Court order to allow shareholders to consider its proposed takeover bid for Sirtex Medical.

  • by Nassim Khadem
US-listed Varian won't match Chinese offer for Sirtex

US-listed Varian won't match Chinese offer for Sirtex

US cancer treatment developer Varian Medical has said it will not increase its offer to buy Australian biotechnology company Sirtex Medical.

  • by Nassim Khadem
Advertisement
Sirtex in trading halt over developments on CDH takeover offer

Sirtex in trading halt over developments on CDH takeover offer

The biotech company said it would make an announcement relating to "material developments" in the $1.9 billion proposal it received from CDH.

  • by Nassim Khadem
Sirtex shares jump on improved earnings

Sirtex shares jump on improved earnings

The biotech company had a strong rally after upping its forecast profit